Anthropic Hit $115, Then Slipped Below $93 Overnight! Is ANT Worth Buying Yet?
Comrades, Anthropic's IPO has just delivered a painful lesson about chasing Wall Street's hottest listings.
It was the largest IPO in US history.
Shares were priced at $83, opened at $111.50 and surged to $115.10.
Then the excitement faded.
ANT closed its first trading day at $97.17.
And here's the latest development.
Overnight trading pushed ANT towards $92.44, below its first-day low of $92.72!
Think about that.
Investors who received shares at the $83 offering price were still sitting on gains.
But anyone who bought at $111.50 was facing a paper loss of approximately 17% at the $92.44 overnight quote.
Same company. Completely different investment outcomes.
So has Anthropic become a buying opportunity, or is the correction only beginning?
🔥 1. The $83 IPO Was a Success. The Opening Trade Was Another Story.
Let's examine the actual price action.
💰 IPO price: $83
🚀 Opening trade: $111.50
🔥 First-day high: $115.10
📉 First-day low: $92.72
💵 Closing price: $97.17
⚠️ Overnight snapshot: approximately $92.44
At the overnight price, ANT had surrendered nearly 20% from its intraday peak.
But here's the distinction.
The IPO itself was successful. That doesn't mean every investor who bought ANT made money.
Investors who secured shares at $83 enjoyed a significant advantage over retail buyers entering after trading began.
That's why I believe buying an IPO at its offering price and chasing it in the aftermarket must be treated as entirely different strategies.
📊 2. Why Anthropic's Valuation Still Concerns Me
Anthropic's growth is undeniably extraordinary.
For the first nine months of 2026:
💰 Revenue: $33.24B
📈 Revenue growth: 1,206% year-on-year
🤖 Annualised revenue run rate: approximately $81B
⚠️ Operating loss: approximately $1.26B
Claude has become an important platform for enterprise AI, coding and automation.
But here's the valuation question.
At $97.17, Anthropic's market capitalisation based on outstanding shares was approximately $1.29 trillion.
Its fully diluted valuation was approximately $1.77 trillion, including additional potential shares.
Those aren't contradictory numbers. They're different share-count calculations.
At the fully diluted valuation, ANT trades at almost 22 times its $81 billion annualised revenue run rate.
And remember, a run rate isn't recognised annual revenue.
There's another staggering number.
Anthropic disclosed approximately $900.9 billion in aggregate contractual commitments, substantially related to computing infrastructure, spread across many years.
This isn't an immediate $900 billion cash bill.
Nevertheless, it demonstrates how expensive competing in frontier AI has become.
My concern isn't whether Claude can grow. It's whether the earnings and cash flow can eventually justify the valuation investors are paying today.
🐋 3. Cathie Wood's ARK Is Buying. Should We Follow?
Here's an interesting development.
ARK Investment Management reportedly purchased approximately 935,000 Anthropic shares across several ETFs on November 19.
That's a substantial expression of interest.
And it reinforces something important.
Institutional investors still see long-term potential in Anthropic.
But Comrades, I wouldn't automatically interpret ARK's purchase as confirmation of a bottom.
We don't know the exact execution price of every share purchased.
We also don't know how much additional capital ARK may deploy.
And institutional investors often have investment horizons and portfolio constraints very different from retail traders.
A prominent fund buying shares isn't the same as evidence that selling pressure has ended.
Remember, the stock fell substantially from its opening price despite strong IPO demand.
⚖️ 4. The New Danger: $92.72 Has Already Been Tested Overnight
This is the part I'm watching most carefully.
ANT's actual first-day low was $92.72.
Your overnight quote of approximately $92.44 has already slipped below that level.
However, overnight markets are generally thinner than regular trading sessions.
So I'm not treating this as a confirmed technical breakdown yet.
I want to see how buyers respond when normal US trading resumes.
These are my key levels:
🔴 $92.72: First-day low
A decisive breakdown during regular trading would be an important warning.
🔴 $90: Psychological support
If sellers remain aggressive, this becomes my next area to watch.
🔴 $83: IPO reference
A return towards the offering price would mean the initial listing premium has largely disappeared.
But $83 is not guaranteed support.
🟡 $100: First recovery hurdle
Reclaiming this level and holding it would improve sentiment.
🟢 $111.50: Opening-price resistance
A sustainable recovery above this level would suggest considerably stronger demand.
🚀 $115.10: First-day high
Breaking above this level on strong volume would signal renewed bullish momentum.
🎯 5. My Revised ANT Prediction: November 20 to December 4
After considering the overnight weakness, I'm becoming slightly more cautious.
Here are my revised scenarios.
🟢 Bull Case: 20%
ANT: $105–$120
Buyers defend the first-day trading area, recover $100 and eventually reclaim $111.50.
Renewed institutional demand and improving AI-sector sentiment support another rally.
🟡 Base Case: 45%
ANT: $88–$105
This is my most likely scenario.
The stock remains volatile as investors debate valuation and wait for a more stable trading range.
I expect relief rallies mixed with renewed selling.
🔴 Bear Case: 35%
ANT: $75–$88
ANT breaks below $92.72 decisively during regular trading.
The loss of $90 attracts more sellers, potentially bringing the stock back towards its $83 IPO price or lower.
These are judgment-based scenarios, not statistically validated forecasts.
My prediction? Anthropic may need a deeper period of price discovery before a sustainable recovery begins.
And I wouldn't be surprised to see another attempt to test $90 before a convincing rebound.
💰 6. How Would I Trade ANT Now?
Personally, I wouldn't chase ANT simply because it has fallen almost 20% from its intraday high.
I'd prefer to watch the first 30–60 minutes of the next regular trading session.
Three things would influence my decision.
First, can ANT reclaim $92.72 and hold above it?
If buyers defend this area during regular trading, that would suggest some stability.
Second, can ANT recover $100?
A sustained move above $100, supported by improving volume, would be more encouraging than a brief price spike.
Third, is the broader AI sector recovering?
If Nvidia, AMD and other technology stocks remain under heavy selling pressure, ANT may struggle even if its business outlook is strong.
I would use limit orders rather than chase volatile overnight quotes.
And I would avoid making an oversized position before a reliable trading range develops.
🧠 7. The Biggest Lesson From This IPO
Here's what I find fascinating.
Anthropic is one of the most exciting AI companies in the world.
Its revenue growth is extraordinary.
Its technology has enormous commercial potential.
And it has attracted substantial institutional demand.
Yet its opening buyers experienced painful losses almost immediately.
A brilliant company doesn't automatically become a brilliant investment at any price.
That's the lesson.
Sometimes the biggest mistake isn't choosing the wrong company.
It's choosing the right company at a price that already assumes years of exceptional growth.
💡 My Final Take: Buy ANT at $92 or Wait?
I'm impressed by Anthropic's growth.
But at this stage, I'm more interested in capital preservation than catching the exact bottom.
My revised base case is volatile trading between $88 and $105.
I want to see buyers regain control of the $92.72 area and eventually reclaim $100.
If the stock breaks below $90 decisively, the risk of a move towards $83 increases.
But if ANT stabilises, attracts sustained institutional demand and breaks back above $111.50, I'll be more constructive.
My conclusion? Anthropic may become one of the great AI investments of this decade. But the most attractive entry may arrive after the IPO excitement fades.
I'd rather miss the first few dollars of a genuine recovery than buy every decline and watch my capital shrink.
Comrades, what's your move?
Would you buy ANT near $92, wait for $83, or only enter after $100 is reclaimed?
I am not a financial advisor. Trade wisely, Comrades!
If you find this post interesting, give it wings! 🪽 Repost and share the insights. Do consider 'Follow me' and get firsthand read of my daily new post. Thank you
@Tiger_SG @TigerEvents @Daily_Discussion @TigerStars @TigerPM
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- 1PC·11-20 22:37Nice Sharing 😁 @Shyon @koolgal @JC888 @Barcode @Aqa @DiAngel @Shernice軒嬣 2000LikeReport
